| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |